亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Methods for Diagnosing and Treating Pediatric Neoplasm

总结
Lead Inventors: Anna Lasorella, MDProblem or Unmet Need:The mortality from pediatric cancers can be reduced if tumors are diagnosed and treated at an early stage. Moreover, current treatment protocols can be invasive (surgery) or can produce deleterious side-effects. Side-effects are a particular concern in pediatric neoplasms because chemotherapy and radiation can interfere with growth and thus generate serious consequences. It is clear that alternative strategies for diagnosis and treatment of pediatric neoplasms are needed in order to achieve earlier diagnosis, improve survival in children with cancer, and ease the negative effects of therapy. The Id proteins are helix-loop-helix transcription factors that have been implicated in the control of cell differentiation and cell-cycle control. Id2 mRNA is overexpressed in pancreatic cancer and certain leukemias. However, prior to this technology the role of Id2 is unclear in pediatric neoplasm. This technology discovered that Id2 is highly expressed in tumors of subjects who have neuroblastoma, and that inhibition of Id2 interrupts the Myc-Id2 transcription pathway and has an antiproliferative effect.
技术优势
Provides early diagnosis for pediatric neoplasm Provides alternative treament for pediatric neoplasm to avoid invasive surgery and side effects caused by chemotherapy and radiation
技术应用
Diagnosis and monitoring of neuroblastomas and other pediatric neoplasms Assessing the efficacy of therapy to treat pediatric neoplasm Assessing the prognosis of pediatric neoplasm Treatment of pediatric neoplasm by inhibiting Id2 Diagnosis, monitoring, and treatment of other types of neoplasm
详细技术说明
This technology discovered that Id2 is highly expressed in tumors of subjects who have neuroblastoma, and that inhibition of Id2 interrupts the Myc-Id2 transcription pathway and has an antiproliferative effect.
*Abstract
None
*Inquiry
Peter Golikov Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu
*IR
1917
*Principal Investigation
*Publications
Cancer Research. 2002 Jan 1;62(1):301-6Oncogene. 2001 Dec 20;20(58):8326-33
*Web Links
Patent number: US20060121494: US20060121494
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备